Photoredox-catalyzed deuteration and tritiation of pharmaceutical compounds

Science. 2017 Dec 1;358(6367):1182-1187. doi: 10.1126/science.aap9674. Epub 2017 Nov 9.

Abstract

Deuterium- and tritium-labeled pharmaceutical compounds are pivotal diagnostic tools in drug discovery research, providing vital information about the biological fate of drugs and drug metabolites. Herein we demonstrate that a photoredox-mediated hydrogen atom transfer protocol can efficiently and selectively install deuterium (D) and tritium (T) at α-amino sp3 carbon-hydrogen bonds in a single step, using isotopically labeled water (D2O or T2O) as the source of hydrogen isotope. In this context, we also report a convenient synthesis of T2O from T2, providing access to high-specific-activity T2O. This protocol has been successfully applied to the high incorporation of deuterium and tritium in 18 drug molecules, which meet the requirements for use in ligand-binding assays and absorption, distribution, metabolism, and excretion studies.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Carbon / chemistry
  • Catalysis
  • Deuterium / chemistry*
  • Deuterium Oxide / chemistry
  • Hydrogen Bonding
  • Isotope Labeling
  • Ligands
  • Oxidation-Reduction
  • Pharmaceutical Preparations / chemistry*
  • Photochemical Processes
  • Tritium / chemistry*
  • Water / chemistry

Substances

  • Ligands
  • Pharmaceutical Preparations
  • Water
  • Tritium
  • tritium oxide
  • Carbon
  • Deuterium
  • Deuterium Oxide